CClinicalTrials.gg
CompletedNCT02474823Updated Jan 18, 2017

Neck Grasp as a Predictor of Sleep Apnea

An interventional study of polysomnogram and home sleep test in Obstructive Sleep Apnea and Type 2 Diabetes, sponsored by Bassett Healthcare. Completed at 1 site in United States. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2017-01-18.

Sponsored by Bassett Healthcare · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
45
Allocation
Not applicable
Ages
18 Years to 70 Years
Sex
All
01

Study summary

A previous pilot study on the use of self neck grasp, ESAP (Easy Sleep Apnea Predictor), showed a positive maneuver (unable to wrap hands completely around neck) to be 100% predictive of sleep apnea in a sleep clinic population. The investigators now would like to compare ESAP to other tests used to diagnose and screen for Sleep Apnea in type 2 diabetics. The tests will included Home Sleep Testing, sleep questionnaires Berlin and STOP-BANG and polysomnogram (PSG). Patients with type 2 diabetes in the Bassett Endocrine Clinic who are scheduled for a routine evaluation will be recruited to undergo; a Home Sleep Test along with two sleep questionnaires PSG. The screen test wil be compared to the results of the gold standard diagnostic test the PSG for their predictive value os OSA in the type 2 diabetic population.

Read the detailed description

The goal is to evaluate the ESAP study (simple neck grasp) as a predictor of Obstructive Sleep Apnea (OSA) in combination with, and in comparison to; Home Sleep Test ( HST), Berlin Sleep Questionnaire and STOP-BANG questionnaire. All predictors are being evaluated against the gold standard test, the polysomnogram (PSG).

OSA is the common disorder affecting 3-7% of the adult population. It has many negative health consequences such as; cardiovascular disease, diabetes, motor vehicle accidents and depression. Data from both epidemiological and clinical studies suggest that OSA is also independently associated with alterations in glucose metabolism and places patients at an increased risk of the development of type 2 diabetes It is often missed in a busy practice. This simple diagnostic tool may help us in identifying the patient at an earlier stage, thus also helping to prevent further complications in diabetic patients.

Participants will undergo 3 study visits/procedures:

Visit 1: Participants will be consented for the study, undergo the ESAP test, complete the Berlin Sleep Questionnaire \& STOP-BANG questionnaire, and provide medical history/demographic information.

Visit 2: Participants will undergo a PSG at the Bassett Sleep Lab.. Visit 3: The morning the PSG is completed, participants will be given the HST recorder and instructed in its use in order to complete the HST. Participants can then drop off the HST recorder at any Bassett Clinic and it will be returned to the Sleep Lab in Cooperstown.

The ESAP test, Berlin Sleep Questionnaire, and the STOP-BANG Questionnaire will be administered by a study coordinator, research nurse, and/or research assistant. The PSG and the HST will be read and evaluated by independent evaluators/physicians. These physicians will not have access to the ESAP or the questionnaire results prior to the evaluation of the PSG or HST.

If a participant has any test (except the ESAP test alone) that is indicative or suspicious for OSA, a study physician will review these results and advise them of any further follow up recommendations.

02

Conditions studied

  • Obstructive Sleep Apnea
  • Type 2 Diabetes
03

In context

Apnea

1,422 studies on the registry are indexed under Apnea; 159 are open to participants now.

This study's enrollment of 45 is close to the median of 50 across 965 interventional studies indexed under Apnea.

Browse Apnea studies →

Lead sponsor

Bassett Healthcare is the lead sponsor of 22 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 18 - 70 years old regardless of gender
  • Confirmed diagnosis of Type 2 diabetes

Exclusion criteria

Exclusion Criteria:

  • Unstable Heart failure
  • COPD
  • Neuromuscular disease
  • Mental disorders which would interfere with following directions
  • Persons who are already diagnosed with OSA or persons who have been using CPAP or BiPAP
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
45 participants (actual)

Study arms

  • Other
    Sleep Apnea assessment

    all participants are in the same arm \& undergo the same assessments: PSG, HST, ESAP

    Other: polysomnogram · Other: home sleep test · Other: Easy Sleep Apnea Predictor

Interventions

  • Otherpolysomnogram

    all participants will undergo PSG for assessment of OSA

    Also known as: PSG

  • Otherhome sleep test

    all participants will undergo HST for assessment of OSA

    Also known as: HST

  • OtherEasy Sleep Apnea Predictor

    all participants will undergo ESAP for assessment of OSA

    Also known as: ESAP , self neck grasp

06

What researchers measure

Primary outcomes

  1. Result of ESAP testing

    The ESAP measures a participant's ability to wrap their own hands around their neck, touching thumb to thumb, middle finger to middle finger. A "positive" test (unable to reach around the neck with fingers) would be indicative of the presence of OSA.

    Time frame: 3 months

Secondary outcomes

  1. results of HST

    Positive HST would indicate presence of OSA

    Time frame: 3 months

  2. Result of PSG testing

    Positive PSG would indicate presence of OSA

    Time frame: 3 months

07

Study locations

1 site
  • Bassett Healthcare Network
    Cooperstown, New York 13326, United States
08

References and documents

Publications

  • Edmonds PJ, Gunasekaran K, Edmonds LC. Neck Grasp Predicts Obstructive Sleep Apnea in Type 2 Diabetes Mellitus. Sleep Disord. 2019 Jul 1;2019:3184382. doi: 10.1155/2019/3184382. eCollection 2019. PubMed 31355009 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 18, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02474823
Lead sponsor
Bassett Healthcare
Responsible party
Lee Edmonds, MD (attending physician - Pulmonology, Bassett Healthcare) — Principal investigator
First posted
Jun 18, 2015
Start date
Jul 2015
Primary completion
Jul 2016
Completion
Jul 2016
Last update
Jan 18, 2017

Study contacts

lee edmonds, MD
principal investigator · Bassett Healthcare

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion